The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Sulfinpyrazone in the Prevention of Sudden Death after Myocardial Infarction
Abstract
We report the results of a randomized double-blind, multicenter trial comparing sulfinpyrazone (200 mg four times a day) and a placebo in the prevention of cardiac mortality among 1558 patients followed for an average of 16 months, beginning 25 to 35 days after a documented myocardial infarction. All but one of the 106 deaths in the group were cardiac; 59 were sudden. The reduction in cardiac mortality at 24 months in the sulfinpyrazone group was 32 per cent (P = 0.058), and the reduction in sudden death was 43 per cent (P = 0.041). The benefit of sulfinpyrazone was attributable entirely to a reduction in sudden death during the second through seventh months after infarction, when there were 35 cardiac deaths in the placebo group and 17 in the sulfinpyrazone group (P = 0.021); of these deaths, 24 in the placebo group and six in the sulfinpyrazone group were sudden cardiac deaths -- a sulfinpyrazone-induced 74 per cent reduction in the calculated mortality rate (P = 0.003). We conclude that sulfinpyrazone prevents sudden cardiac death during the high-risk period shortly after an acute myocardial infarction, but that there is no further apparent effect beyond the seventh month after infarction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship
BRESLOW, N. (1970) · Biometrika · doi:10.1093/biomet/57.3.579 · Cited by 1,411
Marginal likelihoods based on Cox's regression and life model
KALBFLEISCH, J. D., & PRENTICE, R. L. (1973) · Biometrika · doi:10.1093/biomet/60.2.267 · Cited by 537
Elwood, P. C., Cochrane, A., Burr, M. L., Sweetnam, P. M., Williams, G., Welsby, E., Hughes, S. J., & Renton, R. (1974) · BMJ · doi:10.1136/bmj.1.5905.436 · Cited by 519
CORONARY PROGNOSTIC INDEX FOR PREDICTING SURVIVAL AFTER RECOVERY FROM ACUTE MYOCARDIAL INFARCTION
NORRIS, R. (1970) · The Lancet · doi:10.1016/s0140-6736(70)90110-8 · Cited by 301
The Anturane Reinfarction Trial Research Group (1978) · New England Journal of Medicine · doi:10.1056/nejm197802092980601 · Cited by 297
Self-citationVismara, L. A., Amsterdam, E. A., & Mason, D. T. (1975) · The American Journal of Medicine · doi:10.1016/0002-9343(75)90315-0 · Cited by 274
Immediate Mortality and Five-Year Survival of Employed Men with a First Myocardial Infarction
Pell, S., & D'Alonzo, G. A. (1964) · New England Journal of Medicine · doi:10.1056/nejm196404302701801 · Cited by 194
Weinblatt, E., Shapiro, S., Frank, C. W., & Sager, R. V. (1968) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.58.8.1329 · Cited by 191
Initial myocardial infarction among 503 Veterans
Beard, O. W., Hipp, H. R., Robins, M., et al. (1960) · The American Journal of Medicine · doi:10.1016/0002-9343(60)90196-0 · Cited by 109
Cited by
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
Aspirin, Sulfinpyrazone, or Both in Unstable Angina: Results of a Canadian Multicenter Trial
Cairns, J. A., Gent, M., Singer, J., Finnie, K. J., Froggatt, G. M., Holder, D. A., Jablonsky, G., Kostuk, W. J., Melendez, L. J., Myers, M. G., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511283132201 · Cited by 1,120
Secondary prevention of vascular disease by prolonged antiplatelet treatment
Antiplatelet Trialists' Collaboration (1988) · BMJ · doi:10.1136/bmj.296.6618.320 · Cited by 1,047
Sample size slippages in randomised trials: exclusions and the lost and wayward.
Schulz, K. F., & Grimes, D. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07882-0 · Cited by 642
Cordoba, G., Schwartz, L., Woloshin, S., Bae, H., & Gotzsche, P. C. (2010) · BMJ · doi:10.1136/bmj.c3920 · Cited by 400
Metadata
- Authors
- The Anturane Reinfarction Trial Research Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1980-01-31
- Volume
- 302
- Issue
- 5
- Pages
- 250-256
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4248335125
- Cited by
- 346
- References
- 10
- FWCI
- 49.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sulfinpyrazone in the Prevention of Sudden Death after Myocardial Infarction. https://app.cochat.ai/papers/10.1056/nejm198001313020502
- The paper
- The Anturane Reinfarction Trial Research Group. (1980). Sulfinpyrazone in the Prevention of Sudden Death after Myocardial Infarction. New England Journal of Medicine. https://doi.org/10.1056/nejm198001313020502
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.